Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthesia transperineal biopsy

Rick Popert, Francesca Kum*, Findlay MacAskill, Luke Stroman, Grace Zisengwe, Jonah Rusere, Kate Haire, Ben Challacombe, Paul Cathcart

*Corresponding author for this work

    Research output: Contribution to journalComment/debatepeer-review

    6 Citations (Scopus)

    Abstract

    The COVID-19 pandemic is impacting all urological cancer services. On March 19th the British Association of Urological Surgeons (BAUS) provided pragmatic guidance for prostate cancer diagnostic services (Table 1).(1).

    Original languageEnglish
    Pages (from-to)329-332
    Number of pages4
    JournalBJU International
    Volume126
    Issue number3
    DOIs
    Publication statusPublished - 1 Sept 2020

    Keywords

    • PCSM
    • prostate cancer
    • uroonc

    Fingerprint

    Dive into the research topics of 'Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthesia transperineal biopsy'. Together they form a unique fingerprint.

    Cite this